Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer

BJU International

Volumn 102, Issue 11, 2008, Pages 1589-1593

  Boormans, Joost L ^a   Wildhagen, Mark F ^a   Bangma, Chris H ^a   Verhagen, Paul C ^a   Van Leenders, Geert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Lymph node metastases; Mortality; Prognosis; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADULT; AGED; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 56649108323     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07904.x     Document Type: Article

References (23)

1. Aus G, Abbou CC, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2005 48 : 546 51
2. Zwergel U, Lehmann J, Wullich B et al. Lymph node positive prostate cancer: long-term survival data after radical prostatectomy. J Urol 2004 171 : 1128 31
3. Ghavamian R, Bergstralh EJ, Blute ML, Slezak J, Zincke H. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol 1999 161 : 1223 8
4. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999 341 : 1781 8
5. Messing EM, Manola J, Yao J et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006 7 : 472 9
6. Daneshmand S, Quek ML, Stein JP et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004 172 : 2252 5
7. Boorjian SA, Houston Thompson R, Siddiqui S et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 2007 178 : 864 71
8. Cheng L, Bergstralh EJ, Cheville JC et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol 1998 22 : 1491 500
9. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003 169 : 849 54
10. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966 50 : 125 8
11. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992 23 : 273 9
12. Kramer SA, Farnham R, Glenn JF, Paulson DF. Comparative morphology of primary and secondary deposits of prostatic adenocarcinoma. Cancer 1981 48 : 271 3
13. Bazinet M, Hamdy SM, Begin LR, Stephenson RA, Fair WR. Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer. Prostate 1992 20 : 311 26
14. Cheng L, Slezak J, Bergstralh EJ et al. Dedifferentiation in the metastatic progression of prostate carcinoma. Cancer 1999 86 : 657 63
15. Hofer MD, Kuefer R, Huang W et al. Prognostic factors in lymph node-positive prostate cancer. Urology 2006 67 : 1016 21
16. Steinberg GD, Epstein J, Piantadosi S, Walsh PC. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974-87. J Urol 1990 144 : 1425 32
17. Sgrignoli AR, Walsh PC, Steinberg GD, Steiner MS, Epstein JI. Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol 1994 152 : 1077 81
18. Cheng L, Zincke H, Blute ML, Bergstrahl EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001 91 : 66 73
19. Cheng L, Pisansky TM, Ramnani DM et al. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol 2000 13 : 113 8
20. Griebling TL, Ozkutlu D, See WA, Cohen MB. Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. Mod Pathol 1997 10 : 804 9
21. Pagliarulo V, Hawes D, Brands FH et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 2006 24 : 2735 42
22. Freeman JA, Esrig D, Grossfeld GD et al. Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer. J Urol 1995 154 : 474 8
23. Schröder FH, Kurth KH, Fossa SD et al. Early versus delayed endocrine treatment of pN1-3, M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846 - a phase III study. J Urol 2004 172 : 923 7